Central Pacific Bank Trust Division increased its position in The Clorox Company (NYSE:CLX – Free Report) by 40.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 785 shares of the company’s stock after buying an additional 225 shares during the period. Central Pacific Bank Trust Division’s holdings in Clorox were worth $127,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox during the 3rd quarter worth approximately $54,000. AQR Capital Management LLC raised its stake in Clorox by 8.6% during the second quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock valued at $39,121,000 after purchasing an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC lifted its position in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after purchasing an additional 10,149 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in shares of Clorox by 60.5% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock worth $3,244,000 after buying an additional 8,957 shares in the last quarter. Finally, Canada Pension Plan Investment Board increased its holdings in shares of Clorox by 1.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 353,394 shares of the company’s stock worth $48,228,000 after buying an additional 5,500 shares during the last quarter. 78.53% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts recently commented on CLX shares. JPMorgan Chase & Co. increased their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Barclays increased their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday. Five analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $155.38.
Clorox Stock Up 0.7 %
Shares of NYSE:CLX opened at $162.89 on Friday. The business’s 50 day moving average is $164.58 and its 200 day moving average is $154.79. The stock has a market cap of $20.16 billion, a P/E ratio of 56.76, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.49 EPS. Sell-side analysts predict that The Clorox Company will post 6.85 EPS for the current year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.00%. Clorox’s dividend payout ratio is currently 170.03%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Investing in Commodities: What Are They? How to Invest in Them
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- The How and Why of Investing in Gold Stocks
- Nebius Group: The Rising Star in AI Infrastructure
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- MarketBeat Week in Review – 12/30 – 1/03
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.